A Study of Radiotherapy Combined With Raltitrexed and Irinotecan in Metastatic or Locally Recurrent Colorectal Cancer

Recurrent Colorectal Cancer Clinical Trial

Official title:
A Phase II Trial of Radiotherapy Combined With Raltitrexed and Irinotecan(CPT-11) in Patients With Metastatic or Locally Recurrent Colorectal Cancer

Status Active, not recruiting

Clinical Trial Summary

The study evaluates the effectiveness of radiotherapy combined with raltitrexed and irinotecan in treating patients who have metastatic or locally recurrent colorectal cancer that has not responded to fluorouracil. The patients will receive radiotherapy combined with raltitrexed and irinotecan, and then the surgeons will evaluate whether they should receive a surgery.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT04499586
Study type	Interventional
Source	Fudan University
Contact
Status	Active, not recruiting
Phase	Phase 2
Start date	January 1, 2019
Completion date	December 1, 2020

View Details

See also
	Status	Clinical Trial	Phase
	Completed	`NCT01862003` - Phase I/II Trial of Antagonism of HER in GI Cancer	Phase 2